

Search for pathogenic changes in the PIK3CA gene in women with HR+/HER- subtype breast cancer from the Republic of Bashkortostan
https://doi.org/10.25557/2073-7998.2022.09.52-55
Abstract
About the Authors
E. M. KagirovaRussian Federation
R. R. Rakhimov
Russian Federation
A. V. Sultanbaev
Russian Federation
R. I. Khusainova
Russian Federation
I. R. Minniahmetov
Russian Federation
References
1. ВОЗ: https://www.who.int/ru/news-room/fact-sheets/detail/breast-cancer.
2. Региональная программа Республики Башкортостан «Борьба с онкологическими заболеваниями», 2019. http://www.onkorb.ru/ru/info/borba-s-onkologicheskimi-zabolevaniyami-regionalnaya-programma-rb-.php
3. Akinleye A., Avvaru P., Furqan M., Song Y., Liu D. Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics. J Hematol Oncol. 2013;6(1):88. doi: 10.1186/1756-8722-6-88.
4. Litton J.K., Burstein H.J., Turner N.C. Molecular Testing in Breast Cancer. Am Soc Clin Oncol Educ Book. 2019;39:e1-e7. doi: 10.1200/EDBK_237715.
5. Martínez-Sáez, O., Chic, N., Pascual, T. et al. Frequency and spectrum of PIK3CA somatic mutations in breast cancer. Breast Cancer Res. 2020; 22(1): 45. https://doi.org/10.1186/s13058-020-01284-9
6. Соколова Т.Н., Алексахина С.Н., Янус Г.А. c cоавт. Частота и спектр мутаций PIK3CA при гормонозависимом HER2-отрицательном распространенном раке молочной железы у российских пациенток. Современная онкология. 2021; 23 (1): 61-67. DOI: https://doi.org/10.26442/18151434.2021.1.200744.
7. Pevzner A.M., Gaptulbarova K.А. et al.: Investigation of somatic PIK3CA gene mutations in breast cancer patients. JBUON 2021; 26(3): 747-752.
Review
For citations:
Kagirova E.M., Rakhimov R.R., Sultanbaev A.V., Khusainova R.I., Minniahmetov I.R. Search for pathogenic changes in the PIK3CA gene in women with HR+/HER- subtype breast cancer from the Republic of Bashkortostan. Medical Genetics. 2022;21(9):52-55. (In Russ.) https://doi.org/10.25557/2073-7998.2022.09.52-55